Advanced Search

Technical Analysis for ARQT - Arcutis Biotherapeutics, Inc.

Grade Last Price % Change Price Change
C 29.62 -9.00% -2.93
ARQT closed down 9.0 percent on Tuesday, May 11, 2021, on 2.48 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: May 31
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ARQT trend table...
Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Down Weakness 0.00%
Upper Bollinger Band Walk Strength -9.00%
Calm After Storm Range Contraction -13.21%
Upper Bollinger Band Walk Strength -13.21%
Wide Bands Range Expansion -13.21%
Upper Bollinger Band Touch Strength -13.21%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.20%
Older End-of-Day Signals for ARQT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
Down 10% about 11 hours ago
Fell Below 50 DMA about 13 hours ago
3x Volume Pace about 14 hours ago
Down 1 ATR about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Organ Systems Autoimmune Diseases Psoriasis Dermatitis Atopic Dermatitis Westlake Atopy Eczema Westlake Village Dermatological Diseases Type I Hypersensitivity Plaque Psoriasis Vitiligo

Is ARQT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 7 Arcutis Biotherapeutics (NASDAQ:ARQT) Is In A Good Position To Deliver On Growth Plans
May 6 Arcutis Biotherapeutics Showcases Pivotal DERMIS-1 and -2 Phase 3 Trial Data for Topical Roflumilast Cream (ARQ-151) in Plaque Psoriasis at EADV Spring Symposium 2021
May 4 Arcutis Biotherapeutics EPS beats by $0.26
May 4 Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update
May 3 Arcutis to Present New Roflumilast Cream Phase 3 Data at The European Academy of Dermatology and Venereology (EADV) Spring Symposium
Apr 30 MESO, MOTS and SALM among premarket gainers
Apr 28 Arcutis to Present at the 2021 Truist Securities Life Sciences Summit
Apr 23 Arcutis' Roflumilast Foam Improves Scalp, Body Psoriasis As Early As Two Weeks After Treatment Initiation
Apr 23 Arcutis Biotherapeutics Showcases New Roflumilast Data in Psoriasis and Seborrheic Dermatitis at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021
Apr 19 Arcutis Biotherapeutics to Present New Roflumilast Data at The American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX)
See more ARQT news...

Indicators

Indicator Value
52 Week High 39.8527
52 Week Low 17.51
Average Volume 221,464
200-Day Moving Average 27.61
50-Day Moving Average 30.29
20-Day Moving Average 30.81
10-Day Moving Average 32.46
Average True Range 2.34
ADX 18.42
+DI 19.47
-DI 29.06
Chandelier Exit (Long, 3 ATRs ) 29.42
Chandelier Exit (Short, 3 ATRs ) 32.85
Upper Bollinger Band 35.18
Lower Bollinger Band 26.44
Percent B (%b) 0.36
BandWidth 28.36
MACD Line 0.80
MACD Signal Line 0.74
MACD Histogram 0.0618
Fundamentals Value
Market Cap 1.29 Billion
Num Shares 43.6 Million
EPS -1.15
Price-to-Earnings (P/E) Ratio -25.83
Price-to-Sales 0.00
Price-to-Book 6.54
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.01
Resistance 3 (R3) 34.19 32.91 33.27
Resistance 2 (R2) 32.91 31.79 32.81 33.03
Resistance 1 (R1) 31.26 31.10 30.62 31.08 32.79
Pivot Point 29.98 29.98 29.66 29.89 29.98
Support 1 (S1) 28.34 28.86 27.70 28.16 26.45
Support 2 (S2) 27.06 28.17 26.97 26.21
Support 3 (S3) 25.41 27.06 25.97
Support 4 (S4) 25.23